At a forum on health care in Wichita held last Sunday, Dr. Douglas Bradham, DrPH, professor and chair of the Department of Preventive Medicine and Public Health at the KU Medical School-Wichita, said this:
“Direct-to-patient advertising for procedures and for pharmaceuticals, in my mind, should be eliminated.” The audience — a left-leaning group — applauded.
Bradham then gave a few reasons why this advertising is harmful. He’s probably correct in his diagnosis.
But the suppression of free speech that would be necessary to implement his recommendation is intolerable. I’m surprised that the audience agreed with Bradham’s proposed restrictions on such a basic human right.